RMG Wealth Management
CRL icon

RMG Wealth Management’s Charles River Laboratories CRL Stock Holding History

RMG Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.72K Hold
5
– – ﹤0.01% 429
2026
Q2 		$1.42K Hold
5
– – ﹤0.01% 468
2026
Q1 		$842 Hold
5
– – ﹤0.01% 550
2025
Q4 		$1.13K Buy
+5
New +$907 ﹤0.01% 380

Other funds holding CRL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Van Berkom & Associates
Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

RMG Wealth Management's CRL Position: Q3 2026 in Review

RMG Wealth Management held its Charles River Laboratories (CRL) position steady in Q3 2026 at 5 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

RMG Wealth Management first reported a position in CRL in Q4 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • RMG Wealth Management held 5 shares of Charles River Laboratories worth $1.72K as of Q3 2026.
  • RMG Wealth Management left its Charles River Laboratories share count unchanged in Q3 2026.
  • Charles River Laboratories made up ﹤0.01% of RMG Wealth Management's portfolio in Q3 2026, its #429 holding.
  • RMG Wealth Management first reported a position in Charles River Laboratories in Q4 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.